Eli Lilly and Company

Associate Director - Global Marketing Preclinical Diagnostics Strategy

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Position Overview

Employment Type: Full time

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Position Description

The Global Marketing Preclinical Diagnostics Strategy Associate Director will lead important commercial initiatives to shape the external diagnostic landscape for preclinical Alzheimer’s Disease (AD). This involves ensuring accurate diagnosis and supporting the launch of Lilly’s assets in key markets. The position reports to Neuroscience Diagnostics Strategy & Operations/Global Marketing/Preclinical AD.

Responsibilities

The Associate Director will run core workstreams that develop infrastructure and guide strategy to improve access to blood-based diagnostics, while building external partnerships across geographies.

AD Platform Integration

  • Lead governance for diagnostics roadmaps focused on preclinical AD
  • Develop an integrated, market-specific go-to-market commercial strategy supporting the AD platform
  • Collaborate across Medical Development, New Product Planning, Forecasting, Finance, and Business Development to align diagnostics and future therapeutics with Lilly’s platform strategy
  • Contribute to internal strategic governance (Strategic Plan, Business Plan, Launch Readiness, Innovation Readiness, Brand Plan, and senior leadership reviews)

Environment Development and Assessment

  • Assess and shape market readiness for diagnostics and therapeutics—focusing on access, reimbursement, and advocacy engagement
  • Guide prioritized geographies in building preclinical Alzheimer Diagnostic strategies
  • Collaborate with PRA, Corporate Affairs, and Medical Development to address environmental barriers, particularly around access to blood-based diagnostics
  • Monitor diagnostic environment evolution and deliver insights/recommendations to senior leadership and external collaborators
  • Provide guidance and materials for affiliates supporting Diagnostics strategy focusing on availability, access, and adoption.

Infrastructure and Alliance Management

  • Support Diagnostics manufacturer partnerships and contracts to expand availability of blood-based biomarkers and companion diagnostics
  • Lead global diagnostics commercialization strategy and support affiliate execution
  • Drive commercialization strategies and partnerships in priority geographies (US & Outside US) to accelerate diagnostic adoption

Qualifications

Basic Qualifications

  • Bachelor’s degree
  • Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization and/or visas for this role.

Additional Preferences

  • Minimum of 5 years of marketing experience
  • Cross-functional leadership, new product launches, strategic development
  • OUS and/or IBU experience
  • Launch experience in AD and/or diagnostics
  • Background in Pharmaceutical or Diagnostics
  • Strong critical thinking, teamwork across teams with varied strengths, and leadership in ambiguity
  • Fast learner with curiosity, agility, and an innovative demeanour
  • Excellent communicator with strong negotiation and influencing skills
  • Ability to prioritize and drive decision-making in dynamic environments

Equal Opportunity

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form for further assistance. Please note this is for individuals to request an accommodation as part of the application.

Skills

Marketing Strategy
Diagnostics
Alzheimer's Disease
Commercial Strategy
Market Access
Reimbursement
Advocacy Engagement
Go-to-Market Strategy
Partnership Building
Strategic Planning
Business Planning
Launch Readiness
Brand Planning

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI